Press coverage about Cutera (NASDAQ:CUTR) has trended somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cutera earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 46.2689791012075 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Cutera (NASDAQ CUTR) traded down $0.05 on Friday, reaching $44.90. 133,556 shares of the company’s stock traded hands, compared to its average volume of 176,141. The firm has a market cap of $628.83, a PE ratio of 59.87, a PEG ratio of 1.34 and a beta of 0.41. Cutera has a 52-week low of $18.50 and a 52-week high of $52.90.
Several research firms have weighed in on CUTR. BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research cut shares of Cutera from a “hold” rating to a “sell” rating in a research report on Monday, January 1st. Finally, Maxim Group restated a “hold” rating on shares of Cutera in a research report on Wednesday, November 8th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. Cutera has a consensus rating of “Buy” and a consensus target price of $37.33.
TRADEMARK VIOLATION NOTICE: This piece was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://stocknewstimes.com/2018/02/11/cutera-cutr-receiving-somewhat-positive-press-coverage-study-shows.html.
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.